The Cmo Market Outlook: Emerging markets, key players and future trends

Published by	Business Insights
Published	November, 2009	Product code	103176
Content info	98 pages
Price	US $ 3835 PDF by E-mail (Single User License) US $ 14381 PDF by E-mail (Global Site License)

Introduction
Related Reports

The Cmo Market Outlook: Emerging markets, key players and future trends published by Business Insights in November, 2009. This report consists of 98 pages and the price starts from US $ 3835.

Introduction

Abstract

Falling productivity and patent expiries are placing increasing pressure on pharmaceutical companies to reduce fix costs including large manufacturing facilities. Sponsors are turning to CMOs in search of time and cost savings and as a way to flexibly manage outsourced manufacturing. Meanwhile the threat of overcapacity combined with inevitable program cancellations following mega-mergers resist the market. The CMO Market Outlook analyzes the market dynamics, drivers and resistors and assesses the structure of the market. China and India are discussed as destinations for outsourced manufacturing including analyses of regulatory changes and patent protection. Industry strategies are detailed and critically examined. Key players in the global, Chinese and Indian markets are also assessed. The industry trends are examined and used to map out the future of the industry including the impact on the landscape of players.

Executive Summary

The contract manufacturing market
CMO market analysis
Emerging regions in the CMO market
Key players in the CMO market
The future of the CMO market

Chapter 1 The contract manufacturing market

Summary
Introduction
Current market drivers
- Sale of captive plants
- Cost pressures encourage outsourcing
- Increasing number of products in development
- Consolidation in the pharmaceutical industry
- Increase in biopharmaceuticals market
- Growth of emerging pharmaceutical markets
Current market restraints
- Overcapacity
- Financial pressures
- Increased competition - low barriers to entry
- Conclusions

Chapter 2 CMO market analysis

Summary
Introduction
- Primary manufacturing
- Secondary manufacturing
Structure of the CMO market
- Advantages of small and medium sized vs. large CMOs
Industry strategies
- Strategic outsourcing
- Diversification
- Biopharmaceutical manufacturing
- Overcapacity
- Pilot plants
Conclusion

Chapter 3 Emerging regions in the CMO market

Summary
Introduction
China
- Drivers of the Chinese contract manufacturing market
- Challenges of the Chinese contract manufacturing market
- China' s regulatory framework
- Intellectual property protection
- Counterfeit drugs
- China' s major contract manufacturing organizations
  - CMOs offering finished drugs services
  - Biopharmaceutical contract manufacturing in China
India
- Size of the Indian CMO market
- Patent situation and implications for foreign direct investment
  - Challenges in current patent law
- India as a preferred offshoring destination
- The new, integrated business model of Indian CMOs
  - Challenges facing the CRAMS business model
- Expansion strategies of India' s major contract manufacturing organizations
- Conclusions

Chapter 4 Key players in the CMO market

Summary
Introduction
Methodology
Catalent
- Company profile
- Business description
- Partnering collaborations and recent deals
Lonza
- Company profile
- Business description
- Partnering collaborations and recent deals
Boehringer Ingelheim (BI)
- Company profile
- Business description
- Partnering collaborations and recent deals
DSM
- Company profile
- Business description
- Partnering collaborations and recent deals
Evonik
- Company profile
- Business description
- Partnering collaborations and recent deals
Patheon
- Company profile
- Business description
- Partnering collaborations and recent deals
Jubilant
- Company profile
- Business description
- Partnering collaborations and recent deals
BASF
- Company profile
- Business description
- Partnering collaborations and recent deals
Fareva
- Company profile
- Business description
- Partnering collaborations and recent deals
Wockhardt
- Company profile
- Business description
- Partnering collaborations and recent deals

Chapter 5 The future of the CMO market

Summary
Introduction
Strategic partnerships
- Biomanufacturing
- Disposable equipment
- Offshoring
- Market outlook

Chapter 6 Appendix

Selected bibliography
Index

List of Figures

Figure 1.1: Contract manufacturing market ($bn), 2006-14e
Figure 1.2: Pharmaceutical manufacturing process
Figure 1.3: Services performed by CMOs and CDMOs
Figure 1.4: Number of FDA approvals (NCEs), 1990-2008
Figure 1.5: Number of products in development by phase, 1998-2009
Figure 1.6: The contract biomanufacturing market ($bn), 2009-14e
Figure 2.7: Stages of pharmaceutical manufacturing
Figure 2.8: Outsourced biological vs. non-biological manufacturing market, 2009-14e
Figure 2.9: Sponsors employing strategic outsourcing (%)
Figure 2.10: Installed bioreactor capacity (KL), 2006-13e
Figure 2.11: Geographical distribution of bioreactor capacity (%), 2008-13e
Figure 3.12: Share of pharmaceutical sales growth by region, 2006-09f
Figure 3.13: Chinese API exports, $bn 2007-14e
Figure 3.14: Chinese finished form pharmaceuticals exports 2007-14e, $bn
Figure 3.15: India' s finished dose exports ($bn), 2007-14e
Figure 3.16: India' s API exports ($bn), 2007-14e
Figure 3.17: Indian CRAMS market ($bn), 2007-14e
Figure 3.18: Three waves of Indian opportunity
Figure 5.19: Expectations of outsourcing expenditure change, 2009